A Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea

NCT07200206 · clinicaltrials.gov ↗

RECRUITING

Status

3000

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus

Interventions

BIOLOGICAL: Nirsevimab

Sponsor

Sanofi